Latest news
Loading news…
Harbour Antibodies
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2006 1-10 employees For Profit
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
Harbour Antibodies was acquired by Harbour Biomed in 2016.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 9
Company Info
- Founded
- 2006
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 13
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Dec 19, 2016
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- -0.5
- Trend (90d)
- 7.8
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Harbour Antibodies
Loading news…
FAQs about Harbour Antibodies
People who checked this page also checked these
Browse the full Acquirezy directory.